Fulvenat 250mg Injection

Fulvenat 250mg Injection is a type of hormone therapy medicine used in treatment of estrogen hormone receptor (HR) positive metastatic breast cancer, in post menopausal women when the disease or the cancer has progressed to other body parts after the treatment with some anti-estrogen medication. It acts as a downregulator for estrogen receptors.

Fulvenat 250mg Injection should not be taken if you are pregnant, or plan on becomig pregnant, breastfeeding or if you are taking aspirin or any other pain relievers, have any liver disease, thrombocytopenia, or blood clotting disorder. You should also consult your doctor before taking Fulvenat 250mg Injection if you are taking any supplements, any other medicines or herbal preparations or if you are allergic to medicines and such substances.

The side effects of Fulvenat 250mg Injection includes weakness, back pain, nausea, headache, vomiting, sore throat, constipation, abdominal pain, diarrhoea, cough or swelling at injection site. These are common side effects but you should see a doctor if they persist for long periods. Other serious but rare side effects includes vaginal bleeding and blood clots, and you should immediately see a doctor if you experience these.

Fulvenat 250mg Injection is given as an intramuscular injection. The initial dosage is 500mg that is given on the 1st, 15th and 29th day of the first month and after that it is usually given once a month for as long as prescribed by the doctor. You should always consult a doctor regarding the dosage and administration of Fulvenat 250mg Injection.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Breast Cancer

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Headache

• Vomiting

• Weakness

• Allergic Reaction

• Nausea

• Injection Site Reaction

• Increased Liver Enzymes

• Urinary Tract Infection

• Diarrhoea

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Fuvestrol prefilled syringe is unsafe to use during pregnancy.
  There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

• Are there any breast-feeding warnings?

  Fuvestrol prefilled syringe is probably unsafe to use during breastfeeding. Please consult your doctor.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which have the same composition, strength and form as Fulvenat 250mg Injection , and hence can be used as its substitute.

• Fulviglen 250mg Prefilled Syringe

  Glenmark Pharmaceuticals Ltd

• Fuvestrol Prefilled Syringe

  Cadila Pharmaceuticals Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Are there any missed dose instructions?

  If you miss a dose of Fulvestrant, please consult your doctor.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

This medication belongs to an estrogen receptor antagonist class which works by competitively and reversibly binding to estrogen receptors in cancer cells and downregulating them to prevent estrogen binding. It also degrades the estrogen receptors to which it is bound, further preventing estrogen binding.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.